<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05003193</url>
  </required_header>
  <id_info>
    <org_study_id>fatma.demir1</org_study_id>
    <nct_id>NCT05003193</nct_id>
  </id_info>
  <brief_title>The Effect of Walking in Kidney Transplant Patients</brief_title>
  <official_title>The Effect of Pedometer Assisted Walking on Physical Activity Level and Metabolic Parameters in Patients With Renal Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ege University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ege University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cardiovascular diseases are among the most common causes of death in kidney transplant&#xD;
      patients. Physical activity is of great importance in preventing cardiovascular diseases&#xD;
      after transplantation. Although regular physical activity is recommended in international&#xD;
      guidelines to prevent post-transplant mortality and morbidity in kidney transplant patients,&#xD;
      studies have shown that patients do not follow regular physical activity instructions.The aim&#xD;
      of our project is to examine the effect of pedometer-assisted physical activity on metabolic&#xD;
      parameters after kidney transplantation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with kidney transplant surgery will be randomized to the intervention (n: 34) and&#xD;
      control groups (n: 34), respectively, according to the transplant surgery date. Intervention&#xD;
      and Control groups will be given the same training on the importance of physical activity&#xD;
      during discharge training. The pedometer will be given to the intervention group to evaluate&#xD;
      the activity level, and it will be said that their goal is to take 2000 steps in 20 minutes a&#xD;
      day after discharge. Patients will be asked to carry the pedometer during physical activity,&#xD;
      and to write down the number of steps they take in 20 minutes on the form given to them for&#xD;
      90 days. Patients in the control group will only be advised to do physical activity every day&#xD;
      and will be asked to record the minutes of physical activity they do for 90 days. Metabolic&#xD;
      parameters of the patients in the intervention and control groups will be examined at the end&#xD;
      of the 4th and 12th months. These parameters are blood pressure, body mass index, complete&#xD;
      blood count (hemoglobin, leukocyte, thrombocyte), blood glucose, sodium, potassium, calcium,&#xD;
      liver enzymes, serum creatinine, total and indirect bilirubin, albumin and total cholesterol&#xD;
      levels.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 19, 2020</start_date>
  <completion_date type="Anticipated">November 2022</completion_date>
  <primary_completion_date type="Anticipated">November 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood Pressure</measure>
    <time_frame>Change from Baseline Blood Pressure at 4 months after discharge</time_frame>
    <description>mmHg</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood Pressure</measure>
    <time_frame>Change from Baseline Blood Pressure at 12 months after discharge</time_frame>
    <description>mmHg</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Body Mass Index (BMI)</measure>
    <time_frame>Change from Baseline BMI at 4 months after discharge</time_frame>
    <description>BMI is weight in kilograms divided by height in meters squared. Formula: weight (kg) / [height (m)]2</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Body Mass Index (BMI)</measure>
    <time_frame>Change from Baseline BMI at 12 months after discharge</time_frame>
    <description>BMI is weight in kilograms divided by height in meters squared. Formula: weight (kg) / [height (m)]2</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hemoglobin</measure>
    <time_frame>Change from Baseline Hemoglobin at 4 months after discharge</time_frame>
    <description>g/dL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hemoglobin</measure>
    <time_frame>Change from Baseline Hemoglobin at 12 months after discharge</time_frame>
    <description>g/dL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Leukocyte</measure>
    <time_frame>Change from Baseline Leukocyte at 4 months after discharge</time_frame>
    <description>10^3/µL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Leukocyte</measure>
    <time_frame>Change from Baseline Leukocyte at 12 months after discharge</time_frame>
    <description>10^3/µL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Thrombocyte</measure>
    <time_frame>Change from Baseline Thrombocyte at 4 months after discharge</time_frame>
    <description>10^3/µL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Thrombocyte</measure>
    <time_frame>Change from Baseline Thrombocyte at 12 months after discharge</time_frame>
    <description>10^3/µL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood Glucose</measure>
    <time_frame>Change from Baseline Blood Glucose at 4 months after discharge</time_frame>
    <description>mg/dL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood Glucose</measure>
    <time_frame>Change from Baseline Blood Glucose at 12 months after discharge</time_frame>
    <description>mg/dL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sodium</measure>
    <time_frame>Change from Baseline Sodium at 4 months after discharge</time_frame>
    <description>mEq/L</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sodium</measure>
    <time_frame>Change from Baseline Sodium at 12 months after discharge</time_frame>
    <description>mEq/L</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Potassium</measure>
    <time_frame>Change from Baseline Sodium at 4 months after discharge</time_frame>
    <description>mEq/L</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Potassium</measure>
    <time_frame>Change from Baseline Sodium at 12 months after discharge</time_frame>
    <description>mEq/L</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Calcium</measure>
    <time_frame>Change from Baseline Sodium at 4 months after discharge</time_frame>
    <description>mEq/L</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Calcium</measure>
    <time_frame>Change from Baseline Sodium at 12 months after discharge</time_frame>
    <description>mEq/L</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum Creatinine</measure>
    <time_frame>Change from Baseline Sodium at 4 months after discharge</time_frame>
    <description>mg/dL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum Creatinine</measure>
    <time_frame>Change from Baseline Sodium at 12 months after discharge</time_frame>
    <description>mg/dL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total Bilirubin</measure>
    <time_frame>Change from Baseline Sodium at 4 months after discharge</time_frame>
    <description>mg/dL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total Bilirubin</measure>
    <time_frame>Change from Baseline Sodium at 12 months after discharge</time_frame>
    <description>mg/dL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Indirect Bilirubin</measure>
    <time_frame>Change from Baseline Sodium at 4 months after discharge</time_frame>
    <description>mg/dL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Indirect Bilirubin</measure>
    <time_frame>Change from Baseline Sodium at 12 months after discharge</time_frame>
    <description>mg/dL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>High-density lipoprotein (HDL) cholesterol</measure>
    <time_frame>Change from Baseline Sodium at 4 months after discharge</time_frame>
    <description>mg/dL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>High-density lipoprotein (HDL) cholesterol</measure>
    <time_frame>Change from Baseline Sodium at 12 months after discharge</time_frame>
    <description>mg/dL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Low-density lipoprotein (LDL) cholesterol</measure>
    <time_frame>Change from Baseline Sodium at 4 months after discharge</time_frame>
    <description>mg/dL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Low-density lipoprotein (LDL) cholesterol</measure>
    <time_frame>Change from Baseline Sodium at 12 months after discharge</time_frame>
    <description>mg/dL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Aspartate Aminotransferase</measure>
    <time_frame>Change from Baseline Sodium at 4 months after discharge</time_frame>
    <description>U/L</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Aspartate Aminotransferase</measure>
    <time_frame>Change from Baseline Sodium at 12 months after discharge</time_frame>
    <description>U/L</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Alanine aminotransferase</measure>
    <time_frame>Change from Baseline Sodium at 4 months after discharge</time_frame>
    <description>U/L</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Alanine aminotransferase</measure>
    <time_frame>Change from Baseline Sodium at 12 months after discharge</time_frame>
    <description>U/L</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Alkaline Phosphatase</measure>
    <time_frame>Change from Baseline Sodium at 4 months after discharge</time_frame>
    <description>U/L</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Alkaline Phosphatase</measure>
    <time_frame>Change from Baseline Sodium at 12 months after discharge</time_frame>
    <description>U/L</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Triglyceride</measure>
    <time_frame>Change from Baseline Sodium at 4 months after discharge</time_frame>
    <description>mg/dL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Triglyceride</measure>
    <time_frame>Change from Baseline Sodium at 12 months after discharge</time_frame>
    <description>mg/dL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total Cholesterol</measure>
    <time_frame>Change from Baseline Sodium at 4 months after discharge</time_frame>
    <description>mg/dL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total Cholesterol</measure>
    <time_frame>Change from Baseline Sodium at 12 months after discharge</time_frame>
    <description>mg/dL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Albumin</measure>
    <time_frame>Change from Baseline Sodium at 4 months after discharge</time_frame>
    <description>g/dL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Albumin</measure>
    <time_frame>Change from Baseline Sodium at 12 months after discharge</time_frame>
    <description>g/dL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>glucose in urine</measure>
    <time_frame>Change from Baseline Sodium at 4 months after discharge</time_frame>
    <description>mg/dL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>glucose in urine</measure>
    <time_frame>Change from Baseline Sodium at 12 months after discharge</time_frame>
    <description>mg/dL</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">68</enrollment>
  <condition>Kidney Transplant; Complications</condition>
  <condition>Cardiac Disease</condition>
  <arm_group>
    <arm_group_label>Using a pedometer</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The pedometer will be given to the intervention group to evaluate the activity level and to encourage a walk , it will be said that their goal is to take 2000 steps in 20 minutes a day after discharge. Patients will be asked to carry the pedometer during physical activity, and to write down the number of steps they take in 20 minutes on the form given to them for 90 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Not using a pedometer</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The control group will not be given a pedometer.Patients in the control group will only be instructed to do physical activity every day and will be asked to record the minutes of physical activity they do for 90 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>pedometer</intervention_name>
    <description>2000 steps per day in 20 minutes for 90 days, guided by a pedometer after a kidney transplantation</description>
    <arm_group_label>Using a pedometer</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: • Over the age of 18 and under the age of 65,&#xD;
&#xD;
          -  Kidney transplantation at the center where the study was conducted between the&#xD;
             research dates,&#xD;
&#xD;
          -  There is no activity restriction recommendation by the physician,&#xD;
&#xD;
          -  Patients who agree to participate in the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Multiple organ transplantation at the same time,&#xD;
&#xD;
          -  Death or graft loss/rejection in the hospital before discharge,&#xD;
&#xD;
          -  Patients with physical activity restrictions by the physician,&#xD;
&#xD;
          -  Patients who are re-hospitalized within the first 3 months after discharge&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fatma DEMIR KORKMAZ, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ege University Faculty of Nursing 35000, Izmir, Turkey</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fatma DEMIR KORKMAZ, Professor</last_name>
    <phone>+902323115506</phone>
    <email>fatma.demir@ege.edu.tr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tugba Nur ODEN, PhD Student</last_name>
    <phone>+902323905106</phone>
    <email>tugba.nur.zoturk@ege.edu.tr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ege University</name>
      <address>
        <city>Izmir</city>
        <zip>35040</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fatma DEMIR KORKMAZ, Professor</last_name>
      <phone>+902323115506</phone>
      <email>fatma.demir@ege.edu.tr</email>
    </contact>
    <contact_backup>
      <last_name>Tugba Nur ODEN, PhD Student</last_name>
      <phone>+902323905106</phone>
      <email>tugba.nur.ozturk@ege.edu.tr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Zelle DM, Kok T, Dontje ML, Danchell EI, Navis G, van Son WJ, Bakker SJ, Corpeleijn E. The role of diet and physical activity in post-transplant weight gain after renal transplantation. Clin Transplant. 2013 Jul-Aug;27(4):E484-90. doi: 10.1111/ctr.12149. Epub 2013 Jun 13.</citation>
    <PMID>23758229</PMID>
  </reference>
  <reference>
    <citation>Zelle DM, Corpeleijn E, Klaassen G, Schutte E, Navis G, Bakker SJ. Fear of Movement and Low Self-Efficacy Are Important Barriers in Physical Activity after Renal Transplantation. PLoS One. 2016 Feb 4;11(2):e0147609. doi: 10.1371/journal.pone.0147609. eCollection 2016.</citation>
    <PMID>26844883</PMID>
  </reference>
  <reference>
    <citation>Lorenz EC, Amer H, Dean PG, Stegall MD, Cosio FG, Cheville AL. Adherence to a pedometer-based physical activity intervention following kidney transplant and impact on metabolic parameters. Clin Transplant. 2015 Jun;29(6):560-8. doi: 10.1111/ctr.12553. Epub 2015 May 26.</citation>
    <PMID>25845820</PMID>
  </reference>
  <reference>
    <citation>Gustaw T, Schoo E, Barbalinardo C, Rodrigues N, Zameni Y, Motta VN, Mathur S, Janaudis-Ferreira T. Physical activity in solid organ transplant recipients: Participation, predictors, barriers, and facilitators. Clin Transplant. 2017 Apr;31(4). doi: 10.1111/ctr.12929. Epub 2017 Mar 14.</citation>
    <PMID>28185297</PMID>
  </reference>
  <reference>
    <citation>Aakhus S, Dahl K, Widerøe TE. Cardiovascular disease in stable renal transplant patients in Norway: morbidity and mortality during a 5-yr follow-up. Clin Transplant. 2004 Oct;18(5):596-604.</citation>
    <PMID>15344967</PMID>
  </reference>
  <reference>
    <citation>Ojo AO. Cardiovascular complications after renal transplantation and their prevention. Transplantation. 2006 Sep 15;82(5):603-11. Review.</citation>
    <PMID>16969281</PMID>
  </reference>
  <reference>
    <citation>Berben L, Engberg SJ, Rossmeissl A, Gordon EJ, Kugler C, Schmidt-Trucksäss A, Klem ML, Sereika SM, De Simone P, Dobbels F, De Geest SM; B-SERIOUS consortium. Correlates and Outcomes of Low Physical Activity Posttransplant: A Systematic Review and Meta-Analysis. Transplantation. 2019 Apr;103(4):679-688. doi: 10.1097/TP.0000000000002543.</citation>
    <PMID>30461720</PMID>
  </reference>
  <reference>
    <citation>Dontje ML, de Greef MH, Krijnen WP, Corpeleijn E, Kok T, Bakker SJ, Stolk RP, van der Schans CP. Longitudinal measurement of physical activity following kidney transplantation. Clin Transplant. 2014 Apr;28(4):394-402. doi: 10.1111/ctr.12325. Epub 2014 Mar 17.</citation>
    <PMID>24635476</PMID>
  </reference>
  <reference>
    <citation>Gordon EJ, Prohaska TR, Gallant MP, Sehgal AR, Strogatz D, Yucel R, Conti D, Siminoff LA. Longitudinal analysis of physical activity, fluid intake, and graft function among kidney transplant recipients. Transpl Int. 2009 Oct;22(10):990-8. doi: 10.1111/j.1432-2277.2009.00917.x. Epub 2009 Jul 10.</citation>
    <PMID>19619168</PMID>
  </reference>
  <reference>
    <citation>Hawkins MS, Sevick MA, Richardson CR, Fried LF, Arena VC, Kriska AM. Association between physical activity and kidney function: National Health and Nutrition Examination Survey. Med Sci Sports Exerc. 2011 Aug;43(8):1457-64. doi: 10.1249/MSS.0b013e31820c0130.</citation>
    <PMID>21200336</PMID>
  </reference>
  <reference>
    <citation>Svensson M, Jardine A, Fellström B, Holdaas H. Prevention of cardiovascular disease after renal transplantation. Curr Opin Organ Transplant. 2012 Aug;17(4):393-400. doi: 10.1097/MOT.0b013e3283560a3b. Review.</citation>
    <PMID>22790074</PMID>
  </reference>
  <reference>
    <citation>Nelson ME, Rejeski WJ, Blair SN, Duncan PW, Judge JO, King AC, Macera CA, Castaneda-Sceppa C; American College of Sports Medicine; American Heart Association. Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association. Circulation. 2007 Aug 28;116(9):1094-105. Epub 2007 Aug 1.</citation>
    <PMID>17671236</PMID>
  </reference>
  <reference>
    <citation>Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant. 2009 Nov;9 Suppl 3:S1-155. doi: 10.1111/j.1600-6143.2009.02834.x.</citation>
    <PMID>19845597</PMID>
  </reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>March 30, 2021</study_first_submitted>
  <study_first_submitted_qc>August 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 12, 2021</study_first_posted>
  <last_update_submitted>August 6, 2021</last_update_submitted>
  <last_update_submitted_qc>August 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ege University</investigator_affiliation>
    <investigator_full_name>FATMA DEMIR KORKMAZ</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>transplantation</keyword>
  <keyword>exersize</keyword>
  <keyword>heart diseases</keyword>
  <keyword>kidney</keyword>
  <keyword>nursing care</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

